The Cigna Group (NYSE:CI) Director Donna F. Zarcone Sells 2,088 Shares

The Cigna Group (NYSE:CI – Get Rating) Director Donna F. Zarcone sold 2,088 shares of The Cigna Group stock in a transaction that occurred on Friday, March 10th. The stock was sold at an average price of $271.67, for a total transaction of $567,246.96. Following the completion of the sale, the director now directly owns 25,550 shares in the company, valued at approximately $6,941,168.50. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

The Cigna Group Stock Down 0.3 %

Shares of NYSE:CI opened at $272.13 on Wednesday. The Cigna Group has a 52-week low of $227.94 and a 52-week high of $340.11. The firm has a fifty day moving average of $298.52 and a 200 day moving average of $304.99. The firm has a market capitalization of $80.84 billion, a PE ratio of 12.73, a price-to-earnings-growth ratio of 0.99 and a beta of 0.67. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.70 and a current ratio of 0.70.

The Cigna Group (NYSE:CI – Get Rating) last announced its earnings results on Friday, February 3rd. The health services provider reported $4.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.84 by $0.12. The Cigna Group had a net margin of 3.69% and a return on equity of 16.01%. The company had revenue of $45.75 billion during the quarter, compared to analyst estimates of $45.79 billion. During the same period in the previous year, the business earned $4.77 earnings per share. The firm’s quarterly revenue was up .1% compared to the same quarter last year. As a group, research analysts anticipate that The Cigna Group will post 24.65 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 23rd. Shareholders of record on Wednesday, March 8th will be paid a $1.23 dividend. The ex-dividend date is Tuesday, March 7th. This is an increase from The Cigna Group’s previous quarterly dividend of $1.12. This represents a $4.92 annualized dividend and a yield of 1.81%. The Cigna Group’s payout ratio is currently 23.01%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the stock. Stephens reaffirmed an “overweight” rating and issued a $370.00 price target on shares of The Cigna Group in a report on Tuesday, February 28th. StockNews.com cut shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 28th. Wells Fargo & Company cut shares of The Cigna Group from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $370.00 to $355.00 in a report on Tuesday, January 3rd. JPMorgan Chase & Co. lowered their target price on shares of The Cigna Group from $378.00 to $370.00 and set an “overweight” rating on the stock in a report on Thursday, February 23rd. Finally, Raymond James lowered their target price on shares of The Cigna Group from $370.00 to $350.00 and set an “outperform” rating on the stock in a report on Tuesday, February 7th. Seven investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $339.00.

Institutional Trading of The Cigna Group

Hedge funds have recently added to or reduced their stakes in the business. Householder Group Estate & Retirement Specialist LLC bought a new stake in The Cigna Group in the third quarter worth $34,000. RFG Advisory LLC raised its stake in shares of The Cigna Group by 13.0% during the second quarter. RFG Advisory LLC now owns 1,697 shares of the health services provider’s stock valued at $478,000 after acquiring an additional 195 shares during the last quarter. Sigma Planning Corp raised its stake in shares of The Cigna Group by 1.4% during the third quarter. Sigma Planning Corp now owns 4,711 shares of the health services provider’s stock valued at $1,307,000 after acquiring an additional 65 shares during the last quarter. Creative Planning raised its stake in shares of The Cigna Group by 3.7% during the second quarter. Creative Planning now owns 33,692 shares of the health services provider’s stock valued at $8,879,000 after acquiring an additional 1,196 shares during the last quarter. Finally, Trust Co. of Vermont raised its stake in shares of The Cigna Group by 33.5% during the third quarter. Trust Co. of Vermont now owns 7,838 shares of the health services provider’s stock valued at $2,174,000 after acquiring an additional 1,967 shares during the last quarter. 87.61% of the stock is owned by institutional investors.

The Cigna Group Company Profile

(Get Rating)

The Cigna Group is engaged in the provision of global health services. It operates through the following segments: Evernorth, U.S. Medical, International Markets, and Group Disability and Other. The Evernorth segment includes a broad range of coordinated and point solution health services, including pharmacy solutions, benefits management solutions, care solutions and intelligence solutions.